Abrams Royal Pharmacy is voluntarily recalling all unexpired lots of sterile products due to concerns of lack of sterility assurance. 

This recall follows a single report of an adverse event of a patient who received a compounded medication from the pharmacy.

RELATED: Infectious Diseases Resource Center

Affected products include injectables, IVs, eye drops, pellet implants, nasal sprays, inhalation solutions, and eye ointments. If there is contamination in products intended to be sterile, patients are at risk for serious and possibly fatal infections.

Recalled products were distributed to healthcare facilities, physicians, and patients from June 17, 2013 through December 17, 2013. Abrams Royal Pharmacy is notifying its customers by mail and is arranging for return of all recalled medication.

For more information call (214) 349-8000 or visit the FDA MedWatch page.